Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-01 Sale |
2021-03-03 4:31 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
15,000 | $35.51 | $532,640 | 1,925,356 (Indirect Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 4:35 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
11,000 | $47.08 | $517,923 | 1,940,356 (Indirect Direct) |
View |
| 2021-02-01 Sale |
2021-02-03 5:50 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
11,000 | $41.98 | $461,785 | 1,951,356 (Indirect Direct) |
View |
| 2021-01-19 Sale |
2021-01-21 4:16 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
11,000 | $46.53 | $511,793 | 1,962,356 (Indirect Direct) |
View |
| 2021-01-19 Sale |
2021-01-20 4:16 pm |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
2,000 | $46.52 | $93,045 | 24,000 (Direct) |
View |
| 2021-01-05 Sale |
2021-01-07 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
11,000 | $49.34 | $542,757 | 1,973,356 (Indirect Direct) |
View |
| 2020-12-28 Sale |
2020-12-30 4:52 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See Remarks |
7,000 | $51.98 | $363,833 | 1,984,356 (Indirect Direct) |
View |
| 2020-12-16 Sale |
2020-12-17 4:39 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See Remarks |
7,000 | $53.01 | $371,065 | 1,991,356 (Indirect Direct) |
View |
| 2020-12-14 Sale |
2020-12-16 6:06 pm |
Y-mAbs Therapeutics Inc. | VYMAB | Gad Thomas See Remarks |
4,000 | $52.89 | $211,546 | 1,648,356 (Indirect) |
View |
| 2020-12-10 Sale |
2020-12-14 4:30 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See Remarks |
100,000 | $50.96 | $5,096,260 | 2,402,356 (Indirect Direct) |
View |
| 2020-11-17 Purchase |
2020-12-04 6:00 pm |
Y-mAbs Therapeutics Inc. | YMAB | Rajah Vignesh SVP and CMO |
1,697 | $46.47 | $78,853 | 1,697 (Indirect) |
View |
| 2020-12-02 Sale |
2020-12-04 06:00 am |
Y-mAbs Therapeutics Inc. | YMAB | Moller-San Pedro Claus Juan Chief Executive Officer |
50,000 | $51.21 | $2,560,622 | 624,828 (Indirect Direct) |
View |
| 2020-12-01 Sale |
2020-12-02 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
4,000 | $51.42 | $205,685 | 1,652,356 (Indirect) |
View |
| 2020-11-18 Sale |
2020-11-20 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
2,000 | $45.77 | $91,530 | 26,000 (Direct) |
View |
| 2020-11-16 Sale |
2020-11-17 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
4,000 | $46.17 | $184,672 | 1,656,356 (Indirect) |
View |
| 2020-11-03 Sale |
2020-11-05 5:51 pm |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
4,000 | $45 | $180,000 | 28,000 (Direct) |
View |
| 2020-11-02 Sale |
2020-11-05 4:36 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
4,000 | $43.69 | $174,769 | 1,660,356 (Indirect) |
View |
| 2020-10-15 Sale |
2020-10-19 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
4,000 | $39.15 | $156,604 | 1,664,356 (Indirect) |
View |
| 2020-10-01 Sale |
2020-10-02 5:38 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
4,000 | $38.88 | $155,524 | 1,668,356 (Indirect) |
View |
| 2020-09-15 Sale |
2020-09-17 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
4,000 | $40.81 | $163,225 | 1,672,356 (Indirect) |
View |
| 2020-09-10 Sale |
2020-09-15 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
50,000 | $40.98 | $2,049,116 | 3,085,065 (Indirect Direct) |
View |
| 2020-09-01 Sale |
2020-09-02 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
4,000 | $41.6 | $166,390 | 1,676,356 (Indirect) |
View |
| 2020-08-17 Sale |
2020-08-19 4:16 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
4,000 | $40.35 | $161,392 | 1,680,356 (Indirect) |
View |
| 2020-08-11 Sale |
2020-08-13 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
50,000 | $39.91 | $1,995,679 | 1,684,356 (Indirect) |
View |
| 2020-08-03 Sale |
2020-08-05 4:25 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
4,000 | $36.51 | $146,026 | 1,734,356 (Indirect) |
View |
| 2020-07-15 Sale |
2020-07-17 4:18 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
4,000 | $40.06 | $160,229 | 1,738,356 (Indirect) |
View |
| 2020-07-01 Sale |
2020-07-06 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
4,000 | $42.04 | $168,178 | 1,742,356 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-03-10 Other |
2021-03-12 5:40 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
1,029,927 | $0 | 2,655,854 (Indirect) |
View |
| 2021-03-10 Other |
2021-03-12 4:40 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
1,029,927 | $0 | 5,508,392 (Indirect) |
View |
| 2021-03-01 Exercise |
2021-03-03 4:31 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
9,000 | $2 | 1,925,356 (Direct) |
View |
| 2021-03-01 Exercise |
2021-03-03 4:31 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
9,000 | $0 | 1,925,356 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-18 4:35 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
7,000 | $2 | 1,940,356 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-18 4:35 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
7,000 | $0 | 1,940,356 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 5:50 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
7,000 | $2 | 1,951,356 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 5:50 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
7,000 | $0 | 1,951,356 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-21 4:16 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
7,000 | $2 | 1,962,356 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-21 4:16 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
7,000 | $0 | 1,962,356 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-20 4:16 pm |
N/A 2028-04-24 |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
2,000 | $0 | 24,000 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-20 4:16 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
2,000 | $11.16 | 24,000 (Direct) |
View |
| 2021-01-05 Exercise |
2021-01-07 4:15 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
7,000 | $2 | 1,973,356 (Direct) |
View |
| 2021-01-05 Exercise |
2021-01-07 4:15 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
7,000 | $0 | 1,973,356 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-30 4:52 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See Remarks |
7,000 | $2 | 1,984,356 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-30 4:52 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See Remarks |
7,000 | $0 | 1,984,356 (Direct) |
View |
| 2020-12-16 Exercise |
2020-12-17 4:39 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See Remarks |
7,000 | $2 | 1,991,356 (Direct) |
View |
| 2020-12-16 Exercise |
2020-12-17 4:39 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See Remarks |
7,000 | $0 | 1,991,356 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-16 6:06 pm |
N/A 2030-12-15 |
Y-mAbs Therapeutics Inc. | YMAB | Rajah Vignesh SVP & CMO |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-16 6:05 pm |
N/A 2030-12-15 |
Y-mAbs Therapeutics Inc. | YMAB | Lund-Hansen Torben SVP & CTO |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-16 6:05 pm |
N/A 2030-12-15 |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secy & Treas. |
72,350 | $0 | 72,350 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-16 6:04 pm |
N/A 2030-12-15 |
Y-mAbs Therapeutics Inc. | YMAB | Lisby Steen SVP & CSO |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-16 6:04 pm |
N/A 2030-12-15 |
Y-mAbs Therapeutics Inc. | YMAB | Moller-San Pedro Claus Juan Director and CEO |
226,800 | $0 | 226,800 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-16 6:03 pm |
N/A 2030-12-15 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See Remarks |
91,450 | $0 | 91,450 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-16 6:03 pm |
N/A 2030-12-15 |
Y-mAbs Therapeutics Inc. | YMAB | Herman Philip Karl SVP & CCO |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-16 6:02 pm |
N/A 2030-12-15 |
Y-mAbs Therapeutics Inc. | YMAB | Wilms Joris SVP & CCO |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-12-10 Exercise |
2020-12-14 4:30 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See Remarks |
100,000 | $2 | 2,402,356 (Direct) |
View |
| 2020-12-10 Exercise |
2020-12-14 4:30 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See Remarks |
100,000 | $0 | 2,402,356 (Direct) |
View |
| 2020-11-18 Exercise |
2020-11-20 4:15 pm |
N/A 2028-04-24 |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
2,000 | $0 | 26,000 (Direct) |
View |
| 2020-11-18 Exercise |
2020-11-20 4:15 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
2,000 | $11.16 | 26,000 (Direct) |
View |
| 2020-11-03 Exercise |
2020-11-05 5:51 pm |
N/A 2028-04-24 |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
4,000 | $0 | 28,000 (Direct) |
View |
| 2020-11-03 Exercise |
2020-11-05 5:51 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
4,000 | $11.16 | 28,000 (Direct) |
View |
| 2020-09-10 Exercise |
2020-09-15 4:15 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
50,000 | $2 | 3,085,065 (Direct) |
View |
| 2020-09-10 Exercise |
2020-09-15 4:15 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas President and Chairman |
50,000 | $0 | 3,085,065 (Direct) |
View |
| 2020-06-23 Option Award |
2020-06-24 4:49 pm |
N/A 2030-06-23 |
Y-mAbs Therapeutics Inc. | YMAB | Herman Philip Karl SVP & CCO |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-06-23 Option Award |
2020-06-24 4:49 pm |
N/A 2030-06-23 |
Y-mAbs Therapeutics Inc. | YMAB | Rajah Vignesh SVP & CMO |
40,000 | $0 | 40,000 (Direct) |
View |
| 2020-06-23 Option Award |
2020-06-24 4:48 pm |
2020-07-23 2030-06-23 |
Y-mAbs Therapeutics Inc. | YMAB | Hamill Laura Director |
32,000 | $0 | 32,000 (Direct) |
View |